Saturday, August 23, 2025

Red Light Holland, Creso Pharma Walk From Merger Due To COVID Headwinds

Red Light Holland (CSE: TRIP) and Creso Pharma (ASX: CPH) evidently have elected to walk from their previously announced merger arrangement. The termination is being blamed largely on the impacts of the ongoing COVID-19 pandemic.

“Unfortunately, the geographic span of our respective businesses made a merger at this time impractical,” commented Creso’s Chairman Alex Blumenthal.

Among other items related to the previously proposed merger, significant global travel restrictions were identified as a major headwind to bringing the two firms together, with both firms featuring sprawling global operations. The limitations were expected to make integration difficult across all business units, thereby heavily limiting the previously anticipated synergies that the merger would bring.

Despite the merger being mutually terminated, it appears that not all has been lost. The two firms will continue to work together on a go-forward basis, with Creso seeing its products white-labelled by Red Light and distributed across the firms current wholesale channels.

Red Light Holland commented that it will continue to look for M&A opportunities within North America, and that Bruce Linton will remain as Chairman of the firms Advisory Board.

Red Light Holland last traded at $0.26 on the CSE.


FULL DISCLOSURE: Creso Pharma is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Creso Pharma on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

Why Grade Beats Size in Silver Mining | Frank Basa – Nord Precious Metals

Are Investors Missing the Start of the Next Commodity Supercycle? | Morgan Lekstrom – NexMetals

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

US Cannabis: How Will New York Play Out? – The Daily Dive Featuring Bruce Linton

Joining back on the Daily Dive is Bruce Linton, founder and former CEO of Canopy...

Tuesday, September 28, 2021, 01:30:00 PM

Creso Pharma To Merge With Red Light Holland, Creating The HighBrid Lab

Creso Pharma (ASX: CPH) this morning announced that it is set to merge with that...

Wednesday, June 16, 2021, 09:05:59 AM

Creso Pharma Positions Itself For Changing Australian CBD Regulations

Creso Pharma (ASX: CPH) this morning welcomed the advent of changing Australian laws as they...

Monday, February 1, 2021, 07:20:34 AM

Creso’s Canadian Subsidiary Sees $494,000 In Additional Orders

Creso Pharma (ASX: CPH) this morning announced that its Canadian subsidiary, Mernova Medicinal, has obtained...

Wednesday, February 17, 2021, 10:16:02 AM

Red Light Holland To Consult PharmAla On Developing Medical Psilocybin

Red Light Holland (CSE: TRIP) is making moves to enter the clinical side of psilocybin,...

Friday, February 9, 2024, 08:50:24 AM